Author:
Smith Colin M.,Hicks Paul B.,Lindefjeld Jon K.,Taylor Benjamin M.,Fisher Daniel R.,Faragon John J.,Lam Sherrell T.,Pereira Luis F.,Cozza Kelly L.
Publisher
Springer International Publishing
Reference125 articles.
1. Siefried KJ, Mao L, Cysique LA, Rule J, Giles ML, Smith DE, McMahon J, Read TR, Ooi C, Tee BK, Bloch M, de Wit J, Carr A, PAART Study Investigators. Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy. AIDS. 2018;32(1):35–48. https://doi.org/10.1097/QAD.0000000000001685. PMID: 29135584; PMCID: PMC5732638.
2. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, Turner BJ, Eggan F, Beckman R, Vitiello B, Morton SC, Orlando M, Bozzette SA, Ortiz-Barron L, Shapiro M. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001;58(8):721–8. https://doi.org/10.1001/archpsyc.58.8.721. PMID: 11483137.
3. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services; 2019. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 3 June 2020.
4. Piscitelli SC, Gallicano KD. Interactions among drugs for HIV and opportunistic infections. N Engl J Med. 2001;344(13):984–96. https://doi.org/10.1056/NEJM200103293441307. PMID: 11274626.
5. Hansten PD. Drug interactions. In: Koda-Kimble MA, editor. Applied therapeutics: the clinical use of drugs. Vancouver: Applied Therapeutics, Inc.; 1995. p. 1–3.